What considerations determine whether a social/behavioral study qualifies for expedited review?

What considerations determine whether a social/behavioral study qualifies for expedited review?

• A. Typically minimal risk, not involving vulnerable populations, and fitting expedited categories such as noninvasive data collection or analysis of existing data; IRB determines.
• B. Any study with any level of risk qualifies.
• C. Expedited review is only for animal studies.
• D. Expedited review is not applicable to any human subjects research.

Answer: (A)

Expedited review is appropriate when a study presents no more than minimal risk and fits specific categories that the IRB can review without convening the full board. In social and behavioral research, this often means activities like noninvasive data collection or the analysis of existing data in a way that doesn’t identify subjects, as well as studies that collect information through methods routinely used in clinical practice. The IRB makes the final call, ensuring the risk level and the nature of the data fit those predefined categories and that protections for participants (such as avoiding vulnerable populations or handling sensitive topics appropriately) are in place. So, the best fit is a study that is minimally risky, does not involve vulnerable populations, and falls into one of the expedited categories (like noninvasive data collection or analysis of existing data). The other options are incorrect because they either ignore risk levels, incorrectly limit expedited review to animal research, or state that expedited review isn’t available for human subjects research.

Expedited review is appropriate when a study presents no more than minimal risk and fits specific categories that the IRB can review without convening the full board. In social and behavioral research, this often means activities like noninvasive data collection or the analysis of existing data in a way that doesn’t identify subjects, as well as studies that collect information through methods routinely used in clinical practice. The IRB makes the final call, ensuring the risk level and the nature of the data fit those predefined categories and that protections for participants (such as avoiding vulnerable populations or handling sensitive topics appropriately) are in place.

So, the best fit is a study that is minimally risky, does not involve vulnerable populations, and falls into one of the expedited categories (like noninvasive data collection or analysis of existing data). The other options are incorrect because they either ignore risk levels, incorrectly limit expedited review to animal research, or state that expedited review isn’t available for human subjects research.